default author photo

Na Xu

Southern Medical University - Department of Hematology

SCHOLARLY PAPERS

2

DOWNLOADS

111

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Dynamic MRD-Directed Post-Remission Treatment in Patients with Intermediate-Risk Acute Myeloid Leukemia in First Remission: Prospective Validation in a Multicentre Cohort

Number of pages: 32 Posted: 18 Sep 2024
Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Guangxi Medical University, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Southern Medical University - Shenzhen Hospital, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, First People’s Hospital of Chenzhou City, Maoming People’s Hospital, Peking University, Sun Yat-sen University (SYSU), South China University of Technology - Department of Hematology, Jinan University, Southern Medical University, Peking University, Zhongshan City People's Hospital, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Hunan Normal University, Guangxi Medical University, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology and Southern Medical University - Department of Hematology
Downloads 67 (899,324)

Abstract:

Loading...

Dynamic, measurable residual disease, post-remission treatment, intermediate-risk, acute myeloid leukemia

2.

Real-World Evidence-Based Study on Discontinuation of Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia

Number of pages: 27 Posted: 09 Jul 2025
Wuhan Union Hospital, Dian Diagnostics Group Co Ltd, Nanjing Medical University, Sichuan University, Southern Medical University - Department of Hematology, Southern Medical University - Department of Hematology, Zhejiang University - Department of Hematology, Guangxi Medical University, The First People’s Hospital of Jingzhou, Zhengzhou University - Henan Cancer Hospital, Sichuan University, Dian Diagnostics Group Co Ltd, Dian Diagnostics Group Co Ltd, Peking University, Peking University, Zhengzhou University - Henan Cancer Hospital and Huazhong University of Science and Technology - Department of Hematology
Downloads 44 (1,133,231)

Abstract:

Loading...

Chronic myeloid leukaemia, treatment-free remission, prediction model